Registration

ARENTFOX SCHIFF LLP for FOUNDATION MEDICINE, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Policies related to regulatory approval and reimbursment for new oncology diagnostic technologies

LobbyistCovered position, as disclosed
SONJA NESBIT New Deputy Staff Director, Subcommittee on Human Resources, Committee on Ways and Means; Professional Staff, Subcommittee on Human Resources, Committee on Ways and Means
DAN RENBERG New Member, Board of Directors, Ex-Im Bank; Leg. Director and Dep. Chief of Staff. Sen. Arlen Specter

Medicare/Medicaid MMM

Policies related to regulatory approval and reimbursment for new oncology diagnostic technologies

LobbyistCovered position, as disclosed
SONJA NESBIT New Deputy Staff Director, Subcommittee on Human Resources, Committee on Ways and Means; Professional Staff, Subcommittee on Human Resources, Committee on Ways and Means
DAN RENBERG New Member, Board of Directors, Ex-Im Bank; Leg. Director and Dep. Chief of Staff. Sen. Arlen Specter

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
F. HOFFMANN-LA ROCHE AG Switzerland Switzerland 57.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.